Expression of mRNA for a newly identified Pax5 exon is reduced in multiple myeloma.

Borson, Nancy D; Lacy, Martha Q; Wettstein, Peter J

Borson, Nancy D; Lacy, Martha Q; Wettstein, Peter J.

Affiliation

Borson ND; Department of Immunology, Mayo Clinic, Rochester, Minnesota, 55901, USA. borson.nancy@mayo.edu

Mamm Genome ; 17(3): 248-56, 2006 Mar.

Article in En | MEDLINE | ID: mdl-16518692

Subject(s)

Exons/genetics; Gene Expression Regulation, Neoplastic; Multiple Myeloma/genetics; PAX5 Transcription Factor/genetics; RNA, Messenger/metabolism; RNA, Neoplasm/metabolism; Alternative Splicing; Amino Acid Sequence; B-Lymphocytes/metabolism; Base Sequence; Heterozygote; Homozygote; Humans; Molecular Sequence Data; Multiple Myeloma/metabolism; PAX5 Transcription Factor/metabolism; Plasma Cells/metabolism; Protein Isoforms/genetics; Protein Isoforms/metabolism; RNA, Messenger/genetics; Reverse Transcriptase Polymerase Chain Reaction

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: RNA, Messenger / RNA, Neoplasm / Gene Expression Regulation, Neoplastic / Exons / PAX5 Transcription Factor / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mamm Genome Year: 2006 Document type: Article

Search on Google

XML

PubMed Links